MoonLake Immunotherapeutics (MLTX) Shares Outstanding (Entity) (2020 - 2026)
Powered by 
Analysis
MoonLake Immunotherapeutics (MLTX) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 218.28 Mn |
| 10 | MoonLake Immunotherapeutics | 1.10 Bn | 565.05 Mn | - | 85.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85.11 Mn |
| Mar 31, 2026 | 73.62 Mn |
| Dec 31, 2025 | 71.37 Mn |
| Sep 30, 2025 | 63.70 Mn |
| Jun 30, 2025 | 63.47 Mn |
| Mar 31, 2025 | 63.47 Mn |
| Dec 31, 2024 | 63.08 Mn |
| Sep 30, 2024 | 63.05 Mn |
| Jun 30, 2024 | 62.87 Mn |
| Mar 31, 2024 | 62.87 Mn |
| Dec 31, 2023 | 62.97 Mn |
| Sep 30, 2023 | 53.56 Mn |
| Jun 30, 2023 | 62.45 Mn |
| Mar 31, 2023 | 52.70 Mn |
| Dec 31, 2022 | 52.70 Mn |
| Sep 30, 2022 | 52.70 Mn |
| Jun 30, 2022 | 52.70 Mn |
| Mar 31, 2022 | 11.74 Mn |
| Dec 31, 2021 | 12.16 Mn |
| Sep 30, 2021 | 12.13 Mn |